Board Meetings for BIOFILCHEM

Detailed list of historic and upcoming board meetings.

SymbolCompanyMeeting DatePurposeDescriptionLinks
BIOFILCHEMBiofil Chemicals & Pharmaceuticals Limited30 May 2026Financial Results/Other business mattersTo consider and approve the financial results for the period ended March 31, 2026 and other business matters
BIOFILCHEMBiofil Chemicals & Pharmaceuticals Limited30 May 2026Board Meeting IntimationBIOFIL CHEMICALS & PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 30-May-2026 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2026 and Other business.
BIOFILCHEMBiofil Chemicals & Pharmaceuticals Limited13 Feb 2026Board Meeting IntimationBIOFIL CHEMICALS & PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 13-Feb-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended December 2025 and Other business.
BIOFILCHEMBiofil Chemicals & Pharmaceuticals Limited13 Feb 2026Financial Results1. To consider and approve the financial results for the period ended December 31, 2025 along with Limited Review Report thereon. 2.To consider other routine matters with the permission of the chair.
BIOFILCHEMBiofil Chemicals & Pharmaceuticals Limited13 Nov 2025Board Meeting IntimationBIOFIL CHEMICALS & PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 13-Nov-2025 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2025 and Other business.
BIOFILCHEMBiofil Chemicals & Pharmaceuticals Limited13 Nov 2025Financial ResultsTo consider and approve the financial results for the period ended September 30, 2025
BIOFILCHEMBiofil Chemicals & Pharmaceuticals Limited12 Aug 2025Board Meeting IntimationBIOFIL CHEMICALS & PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 12-Aug-2025 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended June 2025 and Other business.
BIOFILCHEMBiofil Chemicals & Pharmaceuticals Limited12 Aug 2025Financial ResultsTo consider and approve the financial results for the period ended Jun 30, 2025
BIOFILCHEMBiofil Chemicals & Pharmaceuticals Limited30 May 2025Financial Results/Other business mattersTo consider and approve the financial results for the period ended March 31, 2025 and other business matters
BIOFILCHEMBiofil Chemicals & Pharmaceuticals Limited30 May 2025Board Meeting IntimationBIOFIL CHEMICALS & PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 30-May-2025 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2025 and Other business.
BIOFILCHEMBiofil Chemicals & Pharmaceuticals Limited11 Feb 2025Financial Results/Other business mattersTo consider and approve the financial results for the period ended December 31, 2024 and other business matters
BIOFILCHEMBiofil Chemicals & Pharmaceuticals Limited11 Feb 2025Board Meeting IntimationBIOFIL CHEMICALS & PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 11-Feb-2025 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended December 2024 and Other business.
BIOFILCHEMBiofil Chemicals & Pharmaceuticals Limited14 Nov 2024Financial Results/Other business mattersTo consider and approve the financial results for the period ended September 30, 2024 and other business matters
BIOFILCHEMBiofil Chemicals & Pharmaceuticals Limited14 Nov 2024Board Meeting IntimationBIOFIL CHEMICALS & PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 14-Nov-2024 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended September 2024 and Other business.
BIOFILCHEMBiofil Chemicals & Pharmaceuticals Limited13 Aug 2024BIOFIL CHEMICALS & PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 13-Aug-2024 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended June 2024 and Other business.Board Meeting Intimation
Showing page 1 of 7 (95 total items)
Next